METHODS FOR USING KDOP AND KDOP SYNTHASE INHIBITORS FOR THE TREATMENT OF BACTERIAL INFECTION

Details for Australian Patent Application No. 2002252532 (hide)

Owner FAZIX CORPORATION

Inventors FRIEDMAN, Jonathan, M.

Pub. Number AU-A-2002252532

PCT Pub. Number WO2002/078634

Priority 60/279,988 30.03.01 US

Filing date 29 March 2002

Wipo publication date 15 October 2002

Event Publications

3 April 2003 Application Open to Public Inspection

  Published as AU-A-2002252532

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002252533-ESTROGEN RECEPTOR MODULATORS

2002252531-Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon